Download presentation
Presentation is loading. Please wait.
1
The Way Forward Questions Options
2
Where do we want to be – by when?
May 2011: we open ICD-11 alpha browser to public May 2012: we open ICD-11 BETA to public 2015 onwards ICD 20** has a continuous update maintenance platform
3
Where do we want to be – by when?
16 May 2011: we open ICD-11 alpha browser to public viewing & reviewing tool CAVEATs: “interim work” “as is” “don’t try this at home” AIM Engage with expecting outside community Openness, transparency Try out some BETA PROCESS now I want to make a comment I want to make a proposal I want to take part in Field Trials I want to translate I want to use it in special development projects
4
Where do we want to be – by when?
16 May 2012: we open ICD-11 BETA to public CAVEATs: “still interim work” “as is” “may try out in field trials” AIM Engage with expecting outside community – actively Continue Growth: missing dimensions BETA PROCESS now I want to make a comment I want to make a proposal I want to take part in Field Trials (3 years) I want to translate I want to use it in special projects
5
Where do we want to be – by when?
16 May 2015 onwards ICD goes to WHA Print Linearization – Morbidity as today – Official Mortality Lists Simple resolution ICD 20** has a continuous update maintenance Real time update proposals Annual frozen release AIM: replace the current UR process - HOPE Engage with active users Continuous Maintenance PERPETUAL BETA I want to make a comment I want to make a proposal I want to take part in Field Trials I want to translate I want to use it in special projects
6
WHY ? The glass is one third full
Denominator: Minimal Content Model of Mb linearization Definitions Inclusion – Exclusions If applicable: Severity, Temporal We never asked the FULL ICD be 100% complete Beta was aimed at crowdsourcing Start early – start simple - consult often… Near 50 % completion in May 2012 is acceptable
7
would count as the alpha draft ? questions
IM-TAG: Unfinished hierarchies Rare Diseases: Unfinished agenda – finding parents to orphans Dermatology: Linking with others and SNOMED Mortality : Continuity + no conflicts - Morbidity: Make sure all XM is there Dagger/asterisk is resolved DRG’s are supported well Functioning : Ensure ICD – ICF is not conflicting …
8
would count as the alpha draft ? Answer:
Current Level in iCAT ICD-11 alpha browser It can continue to evolve on a daily basis
9
Interim Steps Within Next Year
Continue ingestion in iCAT core filling the glass 2/3 Graded development of Sections Early Ready Needed reviews Cross Sectional TAGs: mortality - morbidity Annotations for Dagger Asterisk Codes Content TAGs may use it as their own review tool
10
Action Steps Within Next Year Next Phases
Additional Content Support Linking with other content developers & owners Wikipedia New Taxonomy of Disease Others… Graded development of Beta Tools Establish key mechanisms – workflows Test out with early adopters (TAGs, Other stakeholders…)
11
Interim Steps Within Next Year
Additional Content Support Linking with other content developers & owners Wikipedia New Taxonomy of Disease Others… Graded development of Beta Tools Establish key mechanisms – workflows Test out with early adopters (TAGs, Other stakeholders…)
12
SAQs Single Assessment Question
VIEWER sees “a category” in the Browser: Is this “category” in the right place? Yes NO Where would you put it? Why – state your reason? Can you point to a web evidence?
13
SAQs Single Assessment Question
VIEWER sees “a tree ” in the Browser: Is this “tree” right place? Yes NO How Where would you put it? Why – state your reason? Can you point to a web evidence?
14
SAQ: Definition If the definition missing please help if you have a definition Simple assessment : Is the definition clear SCALE OK –shows interest, shows approval not Problem solving - does not fit with the Title - paradoxical
15
SAQ: Use Category essential for: Mortality Morbidity Safety Quality
16
SAQ: Utility Category useful for practice 1-5 Primary Care Clinical
Research
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.